Build closer relationships with the right opinion leaders
Monocl transforms your approach to stakeholder mapping and stakeholder engagement, regardless if you are working with opinion leaders, rising stars, physicians or other experts.
Book a demo
While maintaining relationships with Key Opinion Leaders (KOLs) is typically the primary function of the MSL role, identifying and selecting KOLs is a challenge encountered by many companies and MSL teams in both the U.S. and globally. Watch the recent webinar recording to hear a panel of MSL leaders discuss strategies and share techniques for identifying and selecting KOLs along with the implications of getting this process wrong.
Why do MSLs and MSL managers engage rising star experts? What aspects of opinion leader engagement do they find most challenging? How important is the digital footprint of a expert for them? Below is the report based on a survey jointly conducted by Monocl and the MSL Society (themsls.org) in the context of the recent webinar “A Strategic Approach to KOL Selection and the Cost of Getting it Wrong”.
Studies show that 50% of new drug launches fail to meet company expectations. Those who successfully manage to engage and establish closer relationships with the right medical experts, opinion leaders and rising stars as early as possible will gain a competitive edge over the next decade.
Find relevant medical and scientific experts in seconds based on highly targeted characteristics, such as specific research attributes, seniority, trial and funding involvement, past industry collaborations, geographic location, influencing capacity and much more.
Prioritize relevant opinion leaders, rising stars and other experts based on influence, research relevance, collaboration network, career development, trends and much more. Proprietary ranking algorithms ensure that you always look at relevant stakeholders and relevant research activities.
Build stronger relationships and drive stakeholder engagement through seamless work stream integration, collaborative user work spaces, continuous research activity notifications, proactive relationship analysis, advanced export capabilities, project folders for brands, ad boards, therapy areas and much more.
Experience a platform tailored specifically for Medical Affairs. Our attention to detail and end user value have pushed the industry standard. Further increase your efficiency and business performance through custom integrations with other solutions, including CRMs.
“Despite many attempts, our field has lacked a single tool that can handle complex searches and accurately assess multiple types of expert merits to produce an actionable list. Monocl has become a phenomenally valuable tool that not only automates this process for us but also generates results we have been missing.”- VP of Medical Affairs, Big Pharma, US
As a part of their pre-launch activities for a new autoimmune drug, a Big Pharma company used Monocl to tier and prioritize medical experts in EU5 with relevant disease and target experience. The customer was able to characterize the landscape and establish segmentation criteria for two distinct tiers of experts. 2000 candidates were identified and 50 were selected and tiered. Medical experts in tier 1 had international influence and reach, while experts in tier 2 had a strong regional collaboration network. 30% of the tiered experts were new to the customer, and several were emerging opinion leaders. Medical Directors and MSLs used the outcome and established professional relationships with the majority of the tiered candidates.
A global leading wound care company acquired Monocl licenses to establish a Scientific Advisory Board comprising a mix of established opinion leaders and rising stars. Leading diabetic foot ulcer experts and important up-and-coming researchers were identified and evaluated based on multiple and complex criteria. Selected experts were ranked and classified into four different tiers, and a final selection was subsequently made based on accomplishments, scientific merits, media presence, collaborations with key competitors and other factors. The outcome was used to establish an advisory board for the US and Europe.
Reach out directly for a demo.Book a demo